Clinical psychotherapy that uses techniques derived from behaviorism or cognitive psychology, aiming for treatment outcomes that are objectively measurable.
Psychotherapy that seeks to extinguish or inhibit abnormal or maladaptive behavior by reinforcing desired behavior and extinguishing undesired behavior.
All patients received behaviortherapy and, in a double-blind fashion, fluvoxamine or placebo.
3
Interventions: Site-specific behaviortherapy plus 10 mg of sibutramine or placebo.
4
A few trials have found cognitive behaviortherapy, or CBT, may be useful in those cases.
5
In particular, cognitive behaviortherapy, problem solving therapy, and life review therapy are evidence-based and empirically validated.
6
This study shows a significant reduction in healthcare costs following cognitive behaviortherapy for panic disorder with agoraphobia.
7
Yet no studies have compared their efficacy to the current treatment of choice, cognitive behaviortherapy (CBT).
8
Cognitive behaviortherapy involves the patient learning to overcome behavioral avoidance associated with anxiety and challenge unhelpful negative cognitions.
9
Objective: To see whether sibutramine reduced weight more than placebo in obese adolescents who were receiving a behaviortherapy program.
10
Patients then participated in a personalized, intensive behaviortherapy program to remediate their extreme, persisting deficits and disturbances in behavior.
11
Do we really want to put Oedipus on the couch, give Hamlet a quick course of behaviortherapy, start Lear on antipsychotics?
12
This study was the first randomized controlled trial of cognitive behaviortherapy for children and adolescents with anxiety disorders using bidirectional cultural adaptation.
13
Conclusion: The current results support the transportability of CBT and the efficacy of a bidirectional, culturally adapted cognitive behaviortherapy in an underrepresented population.
14
Computerized cognitive behaviortherapy (cCBT) may provide an accessible alternative to face-to-face treatment, but the evidence base in young people is limited.
15
They recommend behaviortherapy for four and five year olds, and U.S. Food and Drug Administration-approved medications for those six years old and older.
16
None of the children were using a combination of behaviortherapy and medication at the outset, although some were using one or the other.